Thrombotic Thrombocytopenic Purpura (TTP)
Hematology·MeSH: Purpura, Thrombotic Thrombocytopenic
Prevalence
0.5 / 100K
5 drugs in development·3 companies·6 clinical trials
Drug Pipeline by Phase
Phase 3(4)
Compare drugs
Frequently asked questions
How many drugs are in development for Thrombotic Thrombocytopenic Purpura (TTP)?
BioSniper tracks 5 drugs in development for Thrombotic Thrombocytopenic Purpura (TTP) across 3 companies.
How many clinical trials target Thrombotic Thrombocytopenic Purpura (TTP)?
There are 6 clinical trials targeting Thrombotic Thrombocytopenic Purpura (TTP) tracked by BioSniper.
What is the prevalence of Thrombotic Thrombocytopenic Purpura (TTP)?
The estimated prevalence of Thrombotic Thrombocytopenic Purpura (TTP) is approximately 0.5 per 100,000 population.
Deep-dive into Thrombotic Thrombocytopenic Purpura (TTP)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis